Positive Results in Linagliptin Trial

In the U.S., African Americans and other ethnic minorities are significantly underrepresented in clinical trials. This is the first published trial of a DPP-4 inhibitor specifically conducted in black or African American adult patients with type 2 diabetes.

Read more

Posted in Drugs Medical Research